A review of the new clinical guidelines of the European Cardiological Society in 2017 on the use of double antiplatelet therapy
- Authors: Erlikh A.D1
-
Affiliations:
- N.E.Bauman City Clinical Hospital №29 of the Department of Health of Moscow
- Issue: Vol 19, No 12 (2017)
- Pages: 8-11
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94906
- DOI: https://doi.org/10.26442/2075-1753_19.12.8-11
- ID: 94906
Cite item
Full Text
Abstract
This material is the most important excerpt from the clinical guidelines of the European Cardiological Society (ECS) in 2017 on the use of double antiplatelet therapy (DAT). Developed on the basis of several dozens of clinical studies, the management of the ECS indicate which DAT drugs should be used and in what cases, for how long and in what patients should DAT be prescribed. In addition, separate sections of the document are devoted to the rules of using DAT in patients undergoing scheduled surgical intervention, as well as in patients who need oral anticoagulants. The latest clinical guidelines on DAT are the most important practical tool for the qualitative work of cardiologists, and will also be useful to doctors of other specialties.
Full Text
##article.viewOnOriginalSite##About the authors
A. D Erlikh
N.E.Bauman City Clinical Hospital №29 of the Department of Health of Moscow
Email: alexeyerlikh@gmail.com
д-р мед. наук, проф., проф. каф. клин. фармакологии и терапии 11020, Russian Federation, Moscow, Gospital'naya pl., d. 2
References
- ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC 2016; 68 (10): 1082-115.
- ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017; 0: 1-48.
- Population Division. Department of Economic and Social Affairs. United Nations. Revision of World Population Prospects. https://esa.un.org/unpd/wpp/
- Kristensen S.D, Knuuti J, Saraste A. et al. Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35: 2383-431.
- Rossini R, Capodanno D, Lettieri C. et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107 (2): 186-94.
